text_1: In rhesus macaques, daily subcutaneous injections of emtricitabine are ineffective at protecting against rectally transmitted simian-human immunodeficiency virus.
text_2: These findings support PrEP trials for HIV prevention in humans and identify promising PrEP modalities.